Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP548278.RAc-yG2yk42fsGkz1I9i8-Fzhpn7l8Jx9MjFpxTu7UVAE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP548278.RAc-yG2yk42fsGkz1I9i8-Fzhpn7l8Jx9MjFpxTu7UVAE130_assertion type Assertion NP548278.RAc-yG2yk42fsGkz1I9i8-Fzhpn7l8Jx9MjFpxTu7UVAE130_head.
- NP548278.RAc-yG2yk42fsGkz1I9i8-Fzhpn7l8Jx9MjFpxTu7UVAE130_assertion description "[To quantify MRD in patients after anti-CD22 recombinant immunotoxin BL22 and other agents, we used a relative quantitative PCR (RQ-PCR) assay using a primer and probe, both patient specific for the immunoglobulin heavy chain rearrangement.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP548278.RAc-yG2yk42fsGkz1I9i8-Fzhpn7l8Jx9MjFpxTu7UVAE130_provenance.
- NP548278.RAc-yG2yk42fsGkz1I9i8-Fzhpn7l8Jx9MjFpxTu7UVAE130_assertion evidence source_evidence_literature NP548278.RAc-yG2yk42fsGkz1I9i8-Fzhpn7l8Jx9MjFpxTu7UVAE130_provenance.
- NP548278.RAc-yG2yk42fsGkz1I9i8-Fzhpn7l8Jx9MjFpxTu7UVAE130_assertion SIO_000772 16675574 NP548278.RAc-yG2yk42fsGkz1I9i8-Fzhpn7l8Jx9MjFpxTu7UVAE130_provenance.
- NP548278.RAc-yG2yk42fsGkz1I9i8-Fzhpn7l8Jx9MjFpxTu7UVAE130_assertion wasDerivedFrom befree-2016 NP548278.RAc-yG2yk42fsGkz1I9i8-Fzhpn7l8Jx9MjFpxTu7UVAE130_provenance.
- NP548278.RAc-yG2yk42fsGkz1I9i8-Fzhpn7l8Jx9MjFpxTu7UVAE130_assertion wasGeneratedBy ECO_0000203 NP548278.RAc-yG2yk42fsGkz1I9i8-Fzhpn7l8Jx9MjFpxTu7UVAE130_provenance.